FR3056227B1 - Methode d'evaluation du potentiel d'irritation oculaire de produits chimiques - Google Patents

Methode d'evaluation du potentiel d'irritation oculaire de produits chimiques Download PDF

Info

Publication number
FR3056227B1
FR3056227B1 FR1658746A FR1658746A FR3056227B1 FR 3056227 B1 FR3056227 B1 FR 3056227B1 FR 1658746 A FR1658746 A FR 1658746A FR 1658746 A FR1658746 A FR 1658746A FR 3056227 B1 FR3056227 B1 FR 3056227B1
Authority
FR
France
Prior art keywords
irritation
category
chemicals
eyes
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1658746A
Other languages
English (en)
French (fr)
Other versions
FR3056227A1 (fr
Inventor
Herve Groux
Francoise Cottrez
Nathalie Alepee
Virginie Leblanc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUNOSEARCH
Original Assignee
IMMUNOSEARCH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1658746A priority Critical patent/FR3056227B1/fr
Application filed by IMMUNOSEARCH filed Critical IMMUNOSEARCH
Priority to US16/334,269 priority patent/US12410472B2/en
Priority to CA3037091A priority patent/CA3037091C/fr
Priority to PCT/EP2017/073675 priority patent/WO2018050927A1/fr
Priority to ES17768146T priority patent/ES2906329T3/es
Priority to PL17768146T priority patent/PL3516070T3/pl
Priority to HUE17768146A priority patent/HUE057698T2/hu
Priority to DK17768146.7T priority patent/DK3516070T3/da
Priority to JP2019515316A priority patent/JP7030795B2/ja
Priority to EP17768146.7A priority patent/EP3516070B1/fr
Publication of FR3056227A1 publication Critical patent/FR3056227A1/fr
Application granted granted Critical
Publication of FR3056227B1 publication Critical patent/FR3056227B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113—PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR1658746A 2016-09-19 2016-09-19 Methode d'evaluation du potentiel d'irritation oculaire de produits chimiques Active FR3056227B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR1658746A FR3056227B1 (fr) 2016-09-19 2016-09-19 Methode d'evaluation du potentiel d'irritation oculaire de produits chimiques
JP2019515316A JP7030795B2 (ja) 2016-09-19 2017-09-19 化学物質の眼刺激性を評価するための方法
PCT/EP2017/073675 WO2018050927A1 (fr) 2016-09-19 2017-09-19 Methode d'evaluation du potentiel d'irritation oculaire de produits chimiques
ES17768146T ES2906329T3 (es) 2016-09-19 2017-09-19 Método de evaluación del potencial de irritación ocular de productos químicos
PL17768146T PL3516070T3 (pl) 2016-09-19 2017-09-19 Sposób oceny potencjału podrażnienia oczu przez produkty chemiczne
HUE17768146A HUE057698T2 (hu) 2016-09-19 2017-09-19 Eljárás kémiai termékek szemirritációs potenciáljának értékelésére
US16/334,269 US12410472B2 (en) 2016-09-19 2017-09-19 Method for evaluating the eye irritation potential of chemicals
CA3037091A CA3037091C (fr) 2016-09-19 2017-09-19 Methode d'evaluation du potentiel d'irritation oculaire de produits chimiques
EP17768146.7A EP3516070B1 (fr) 2016-09-19 2017-09-19 Methode d'evaluation du potentiel d'irritation oculaire de produits chimiques
DK17768146.7T DK3516070T3 (da) 2016-09-19 2017-09-19 Fremgangsmåde til vurdering af øjenirritationspotentialet af kemiske produkter

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1658746 2016-09-19
FR1658746A FR3056227B1 (fr) 2016-09-19 2016-09-19 Methode d'evaluation du potentiel d'irritation oculaire de produits chimiques

Publications (2)

Publication Number Publication Date
FR3056227A1 FR3056227A1 (fr) 2018-03-23
FR3056227B1 true FR3056227B1 (fr) 2021-01-01

Family

ID=57583238

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1658746A Active FR3056227B1 (fr) 2016-09-19 2016-09-19 Methode d'evaluation du potentiel d'irritation oculaire de produits chimiques

Country Status (9)

Country Link
US (1) US12410472B2 (https=)
EP (1) EP3516070B1 (https=)
JP (1) JP7030795B2 (https=)
DK (1) DK3516070T3 (https=)
ES (1) ES2906329T3 (https=)
FR (1) FR3056227B1 (https=)
HU (1) HUE057698T2 (https=)
PL (1) PL3516070T3 (https=)
WO (1) WO2018050927A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
CA2318641A1 (en) * 1998-01-23 1999-07-29 University Of Ottawa Artificial cornea
FR2957090A1 (fr) * 2010-03-05 2011-09-09 Immunosearch Methode d'evaluation du potentiel irritant d'un compose test

Also Published As

Publication number Publication date
JP7030795B2 (ja) 2022-03-07
HUE057698T2 (hu) 2022-05-28
ES2906329T3 (es) 2022-04-18
FR3056227A1 (fr) 2018-03-23
EP3516070A1 (fr) 2019-07-31
DK3516070T3 (da) 2022-02-14
WO2018050927A1 (fr) 2018-03-22
CA3037091A1 (fr) 2018-03-22
US20190300952A1 (en) 2019-10-03
US12410472B2 (en) 2025-09-09
EP3516070B1 (fr) 2021-12-15
PL3516070T3 (pl) 2022-03-28
JP2019537428A (ja) 2019-12-26

Similar Documents

Publication Publication Date Title
Soriano et al. Analytical Nanoscience and Nanotechnology: Where we are and where we are heading
Morita et al. Evaluation of the sensitivity and specificity of in vivo erythrocyte micronucleus and transgenic rodent gene mutation tests to detect rodent carcinogens
MX2022011780A (es) Composiciones que contienen anticuerpos activables.
MA39034A1 (fr) Composés de quinoline sélectivement substitués
FR3034430B1 (fr) Lignee cellulaire surexprimant l'antigene cd303 humain
BRPI0812875A2 (pt) " método pra identificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, anticorpo específico para proteína ligante de heparina, método pra reduzir o risco de um indivíduo desenvolver sépsis severa, e, kit de teste ".
MA30922B1 (fr) Anticorps d'agonistes de trkb et leurs utilisations
Tokunaga et al. Norms and the willingness to pay for coastal ecosystem restoration: A case of the Tokyo Bay intertidal flats
ZA201904613B (en) Methods for the use of galectin 3 binding protein detected in the urine for monitoring the severity and progression of lupus nephritis
FR3056222B1 (fr) Composition a base de 1-chloro-3,3,3-trifluoropropene
EP1536220A4 (en) METHOD FOR EVALUATING THE EFFICIENCY OF AN OPTICAL SYSTEM AND METHOD FOR ITS DRAFT
FR3034523B1 (fr) Nouvelle methode pour detecter la presence de bacteries productrices de beta-lactamases.
MA46988A1 (fr) Formulation liquide d'anticorps anti-tnf alpha
UY40069A (es) Composiciones y métodos para el tratamiento de afecciones oculares
MX2021006183A (es) Composiciones y metodos para diagnosticar y tratar la enfermedad degenerativa de la valvula mitral en un canino.
AR096890A1 (es) Conjugando fc de inmunoglobulina, que mantiene la afinidad de unión del fragmento fc de la inmunoglobulina a fcrn
FR3056227B1 (fr) Methode d'evaluation du potentiel d'irritation oculaire de produits chimiques
EA202190166A1 (ru) Биосенсор мужского бесплодия
Eskes et al. Validation study on the Ocular Irritection® assay for eye irritation testing
WO2015166353A3 (en) Early detection of preeclampsia
MX2020008348A (es) Prediccion de perdida de embarazo.
WO2019197543A3 (en) Periodontitis diagnostic methods, uses and kits
JOP20220086A1 (ar) صياغات منخفضة الحجم تتضمن كيانات حمض أميني
NZ764338A (en) Method of assessing growth hormone deficiency in humans by a macimorelin containing composition
Park The effect of work-family role conflict and spousal support resources on parenting stress among working mothers with pre-school children

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180323

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10